Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Leuko Labs
Boston, Massachusetts, United States
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Leuko Labs has developed a prototype of PointCheck™, a non-invasive, portable device that uses optical imaging and AI algorithms to estimate white blood cell counts through the skin at the fingertip. Clinical testing on 45 chemotherapy patients demonstrated successful identification of dangerously low white blood cell counts. The product aims to enable frequent at-home monitoring, reduce hospitalizations, and improve outcomes for immunosuppressed patients[1][3][7].
- Therapeutic areas
- Infectious DiseasesHematology
- Modalities
- DeviceNon-pharmacological therapy (diagnostic)
- Industry
- Physiological Monitoring
02
Partnerships
Good Growth CapitalHTH VC
Beyond the preview
Go deeper on Leuko Labs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Leuko Labs.